US Stock MarketDetailed Quotes
NHTC Natural Health Trends
- 5.440
- 0.0000.00%
Trading Dec 2 14:30 ET
62.63MMarket Cap90.67P/E (TTM)
5.610High5.410Low17.20KVolume5.410Open5.440Pre Close94.37KTurnover0.25%Turnover Ratio108.80P/E (Static)11.51MShares6.93052wk High1.77P/B36.86MFloat Cap4.92752wk Low0.80Dividend TTM6.78MShs Float4289.940Historical High14.71%Div YieldTTM3.68%Amplitude-0.095Historical Low5.486Avg Price1Lot Size
Natural Health Trends Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 49.83%-436K | -34.95%-3.57M | 178.88%549K | 11.83%-4.28M | -107.36%-69K | 62.05%-869K | -129.51%-2.64M | 70.36%-696K | -577.56%-4.85M | -40.37%938K |
| Net income from continuing operations | -79.65%35K | 179.00%173K | -26.85%188K | 81.47%568K | 90.43%358K | 265.96%172K | -219.67%-219K | 344.76%257K | -71.15%313K | -18.97%188K |
| Depreciation and amortization | -20.51%31K | -24.44%34K | -23.91%35K | -19.61%164K | -29.17%34K | -22.00%39K | -15.09%45K | -13.21%46K | -31.77%204K | -22.58%48K |
| Deferred tax | 231.43%46K | 292.00%48K | 43.86%-32K | -297.78%-178K | -166.30%-61K | -150.00%-35K | -219.05%-25K | -533.33%-57K | -75.14%90K | -68.92%92K |
| Other non cash items | 5.26%280K | -3.87%273K | -2.86%272K | -5.38%1.11M | -1.41%279K | -8.28%266K | -4.38%284K | -7.28%280K | 0.77%1.17M | 5.60%283K |
| Change In working capital | 46.11%-727K | -41.58%-3.92M | 103.86%49K | 7.98%-6.1M | -319.27%-717K | 49.34%-1.35M | -62.25%-2.77M | 51.02%-1.27M | -250.29%-6.63M | -54.27%327K |
| -Change in inventory | 419.27%613K | 146.56%646K | -30.61%-640K | -66.47%228K | 20.00%648K | -244.36%-192K | 176.38%262K | -240.00%-490K | 143.96%680K | 161.93%540K |
| -Change in payables and accrued expense | -559.26%-124K | -24.69%-4.12M | 226.38%206K | -45.65%-3.99M | -5,109.09%-551K | 103.87%27K | -638.48%-3.3M | 89.84%-163K | -104.48%-2.74M | 104.26%11K |
| -Change in other current assets | 133.98%35K | -51.89%-483K | 191.67%88K | -178.05%-722K | -561.29%-205K | -119.15%-103K | -123.77%-318K | 71.34%-96K | 225.85%925K | -234.78%-31K |
| -Change in other current liabilities | 5.15%-460K | 42.16%-369K | -12.81%-634K | 15.86%-2.19M | 0.20%-500K | 23.02%-485K | 30.12%-638K | -1.63%-562K | 30.82%-2.6M | 27.07%-501K |
| -Change in other working capital | -32.72%-791K | -67.16%403K | 2,293.02%1.03M | 119.48%565K | -135.39%-109K | 58.06%-596K | 191.50%1.23M | 109.62%43K | -152.92%-2.9M | -87.72%308K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 49.83%-436K | -34.95%-3.57M | 178.88%549K | 11.83%-4.28M | -107.36%-69K | 62.05%-869K | -129.51%-2.64M | 70.36%-696K | -577.56%-4.85M | -40.37%938K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 54,527.78%9.8M | -62,214.29%-4.36M | -407,400.00%-28.53M | 67.83%-46K | -7.69%-14K | 65.38%-18K | 81.58%-7K | 82.50%-7K | 36.44%-143K | 78.33%-13K |
| Net PPE purchase and sale | 61.11%-7K | -171.43%-19K | -57.14%-11K | 67.83%-46K | -7.69%-14K | 65.38%-18K | 81.58%-7K | 82.50%-7K | 36.44%-143K | 78.33%-13K |
| Net investment purchase and sale | --9.8M | ---4.34M | ---28.51M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 54,527.78%9.8M | -62,214.29%-4.36M | -407,400.00%-28.53M | 67.83%-46K | -7.69%-14K | 65.38%-18K | 81.58%-7K | 82.50%-7K | 36.44%-143K | 78.33%-13K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0.00%-2.3M | 0.04%-2.3M | 0.04%-2.3M | -0.84%-9.22M | -0.92%-2.3M | -0.79%-2.3M | -0.83%-2.3M | -0.83%-2.3M | 0.00%-9.14M | 0.00%-2.28M |
| Cash dividends paid | 0.00%-2.3M | 0.04%-2.3M | 0.04%-2.3M | -0.84%-9.22M | -0.92%-2.3M | -0.79%-2.3M | -0.83%-2.3M | -0.83%-2.3M | 0.00%-9.14M | 0.00%-2.28M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 0.00%-2.3M | 0.04%-2.3M | 0.04%-2.3M | -0.84%-9.22M | -0.92%-2.3M | -0.79%-2.3M | -0.83%-2.3M | -0.83%-2.3M | 0.00%-9.14M | 0.00%-2.28M |
| Net cash flow | ||||||||||
| Beginning cash position | -74.66%15.61M | -61.20%25.86M | -19.40%56.22M | -17.33%69.75M | -17.37%58.45M | -18.63%61.61M | -16.13%66.65M | -17.33%69.75M | -9.18%84.37M | -16.95%70.73M |
| Current changes in cash | 321.25%7.06M | -106.52%-10.23M | -906.95%-30.28M | 4.20%-13.54M | -75.77%-2.39M | 31.06%-3.19M | -42.59%-4.96M | 35.65%-3.01M | -69.32%-14.13M | -76.36%-1.36M |
| Effect of exchange rate changes | 682.35%266K | 81.82%-16K | 16.48%-76K | 102.06%10K | -58.33%155K | 109.66%34K | 68.35%-88K | 60.09%-91K | -170.00%-486K | 1,382.76%372K |
| End cash Position | -60.76%22.94M | -74.66%15.61M | -61.20%25.86M | -19.40%56.22M | -19.40%56.22M | -17.37%58.45M | -18.63%61.61M | -16.13%66.65M | -17.33%69.75M | -17.33%69.75M |
| Free cash flow | 50.06%-443K | -35.31%-3.59M | 176.53%538K | 13.43%-4.32M | -108.97%-83K | 62.13%-887K | -122.77%-2.65M | 70.56%-703K | -731.48%-5M | -38.86%925K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data